Jim Mazzola | SVP, Communication and IR |
Athena Countouriotis | President and CEO |
Yi Larson | EVP and CFO |
Corinne Jenkins | Goldman Sachs |
Jim Birchenough | Wells Fargo |
Michael Schmidt | Guggenheim Partners |
Robert Burns | H.C. Wainwright |
Zegbeh Jallah | ROTH Capital Partners |
Arlinda Lee | Canaccord Genuity |
Ladies and gentlemen, thank you for standing by, and welcome to the Turning Point Therapeutics' First Quarter 2020 Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation there will be a question-and-answer session. [Operator Instructions]
I would now like to hand the conference to your speaker today, Jim Mazzola.